Description

Trade name:

Uripan

Compound:

Each 100 ml of syrup contains:

Oxybutynin hydrochloride 0.1 g.

Auxiliary components:

Sodium saccharin, microcrystalline cellulose, sodium metabisulfite, anise oil, glycerin, purified water.

Properties:

An M-anticholinergic from the group of tertiary amines. Along with moderate M-anticholinergic activity, it has the ability to directly affect the smooth muscles of internal organs (myotropic antispasmodic effect). Eliminates spasms and reduces the tone of smooth muscles of internal organs: gastrointestinal tract, biliary tract, uterus, urinary tract, including the bladder. In neurogenic bladder, oxybutynin relaxes the detrusor of the bladder, reduces spontaneous contractions of the detrusor, increases the capacity of the bladder, and reduces the frequency of urge to urinate.

Indications:

Urinary incontinence due to instability of bladder function of a neurogenic nature (detrusor hyperreflexia, for example, in multiple sclerosis or spina bifida) or idiopathic nature; nocturnal enuresis in children over 5 years of age (as monotherapy or in combination with other drugs).

Method of administration and dosage:

Orally. 2.5 ml (half a teaspoon) 2 times a day. It is possible to increase the dose to 5 ml per day (1 teaspoon) 2 or 3 times a day. The last dose of the drug should be taken before bedtime.

Contraindications:

Violation of urine outflow from the bladder, when precipitation of retained urine is possible; intestinal obstruction; intestinal atony; severe ulcerative colitis; dilation of the colon; myasthenia; glaucoma; lactation (breastfeeding); children under 5 years of age; hypersensitivity to oxybutynin.

Precautions:

Use with caution in elderly patients, with neurocirculatory dystonia, liver or kidney dysfunction, thyrotoxicosis, arrhythmia, coronary heart disease, chronic heart failure, arterial hypertension, initial manifestations of benign prostatic hyperplasia, ulcerative colitis, in patients with ileostomy, colostomy, and esophageal hernia accompanied by reflux esophagitis.

Side effects:

From the digestive system: dry mouth, nausea, constipation, abdominal discomfort, diarrhea are possible.

From the central nervous system: headache, drowsiness, dizziness, decreased visual acuity are possible.

Dermatological reactions: dry skin may occur.

Others: hot flashes (more common in children), difficulty urinating, urinary retention, arrhythmia are possible.

Storage method:

At a temperature not exceeding 30 degrees. In a dry, cool place.

Package:

The cardboard box contains a 120 ml bottle and paper instructions.